
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 May 21
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Own the complete customer and patient journey from initial patient registration through legally compliant product sale and invoicing. • Ensure consistent, on-time execution of scheduling, delivery, and patient support across all cellular therapy programs. • Serve as the single point of accountability for customer operations outcomes, including service quality, operational performance, scalability, and customer satisfaction. • Serve as a core member of the site activation team, providing executive leadership and operational oversight to design, implement, and scale patient support services in alignment with site readiness, treatment center onboarding, and launch milestones, ensuring seamless integration of patient access, scheduling, reimbursement support, and care coordination workflows from initial site activation through steady-state operations. • Design, launch, and lead a Kyverna-branded Navigator organization serving as the primary interface for CAR T treatment centers. • Establish a unified service model and single point of contact for scheduling, logistics coordination, and patient support. • Drive scale through standardized workflows, technology enablement, and automation. • Own and govern the end-to-end scheduling ecosystem, including digital scheduling portals and enabling technologies. • Ensure tight integration between scheduling, manufacturing, logistics, and patient services. • Partner with IT and Operations to continuously improve system performance, data visibility, and user experience. • Define the enterprise patient support strategy and operating model. • Ensure patient support services are fully integrated with scheduling and site operations. • Build, lead, and develop a high-performing patient support organization focused on consistency, compliance, and quality. • Provide executive oversight of state licensing, government price reporting, trade policy, distributor operations, and order-to-cash execution. • Ensure all commercial activities are conducted in full compliance with regulatory, legal, and contractual requirements. • Partner closely with Finance, Legal, Compliance, and Market Access to manage risk and enable sustainable commercialization. • Define and execute Kyverna’s distributor and channel strategy aligned with commercial and supply chain objectives. • Oversee distributor selection, governance, performance management, and continuous improvement. • Design the future-state customer operations operating model to support pipeline expansion and long-term growth. • Establish enterprise KPIs, SLAs, governance structures, and performance management frameworks.
• Bachelor’s degree required; advanced degree preferred (MBA, MPH, PharmD, or equivalent). • 15+ years of progressive experience in biopharmaceutical operations, customer operations, patient services, trade, distribution, or related functions. • 5+ years of experience in senior leadership roles with enterprise-level accountability. • Demonstrated experience building and leading end-to-end customer operations organizations in specialty pharma, rare disease, oncology, or cellular and gene therapy environments. • Direct experience supporting CAR T or other autologous therapies strongly preferred. • Deep understanding of U.S. trade, distribution, order-to-cash, state licensing, government price reporting, and compliance requirements. • Proven ability to design scalable operating models and lead organizational transformation. • Strong cross-functional leadership and stakeholder management skills across Commercial, Medical Affairs, Clinical Operations, Supply Chain, Finance, Legal, Compliance, and IT. • Experience leading technology-enabled operations, including scheduling platforms, workflow automation, CRM systems, and digital service models. • Demonstrated track record of building high-performing teams and developing senior leaders. • Exceptional strategic thinking, executive communication, and decision-making skills. • Ability to operate effectively in a fast-paced, high-growth, launch-stage environment.
• comprehensive benefits • participation in the Company’s stock option plan • annual bonus
Apply Now🕒 May 20
Director of Account Management at McKesson leading logistics solutions for advanced therapies. Responsible for financial performance and client relationships, with a focus on strategy and execution.
🇺🇸 United States – Remote
💵 $122.8k - $204.6k / year
⏰ Full Time
🔴 Lead
😶🌫️ Therapist
🦅 H1B Visa Sponsor
🕒 May 16
Cell Therapy Business Development Manager responsible for driving growth in Viracor's cell therapy diagnostics through strategic partnerships. Collaborating with treatment centers to enhance test utilization and market presence.
🇺🇸 United States – Remote
💰 $30M Grant on 2021-10
⏰ Full Time
🟠 Senior
🔴 Lead
😶🌫️ Therapist
🦅 H1B Visa Sponsor
🕒 May 16
Cell Therapy Business Development Manager responsible for driving growth in diagnostics for Eurofins Scientific. Partnering closely with stakeholders to expand test utilization in cell therapy.
🇺🇸 United States – Remote
💰 $30M Grant on 2021-10
⏰ Full Time
🟠 Senior
🔴 Lead
😶🌫️ Therapist
🦅 H1B Visa Sponsor
🕒 May 15
Director managing corporate accounts for Infusion Therapy products at Fresenius Kabi. Developing strategic relationships with national accounts in healthcare sectors.
🕒 May 14
Product Director leading commercialization and strategy for oncology therapy selection products. Collaborating across teams to ensure clinical value and market success.
🇺🇸 United States – Remote
💵 $165.2k - $202.4k / year
⏰ Full Time
🔴 Lead
😶🌫️ Therapist
🦅 H1B Visa Sponsor